The ICU-recover Box, Using Smart Technology for Monitoring Health Status After ICU Admission

Sponsor
Leiden University Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT05766319
Collaborator
(none)
10
1
1
10.2
1

Study Details

Study Description

Brief Summary

In this pilot study we will study the feasibility of providing and following ICU patients with smart technology for three months after discharge from a general ward of the Leiden University Medical Centre.

Condition or Disease Intervention/Treatment Phase
  • Device: Withings ScanWatch
  • Device: Withings BPM Connect
  • Device: Withings Body
N/A

Detailed Description

Rationale: Smart technology could improve quality of care in patients who have been admitted to the ICU and have been discharged from ICU and hospital, by early diagnosis of complications and early (ambulatory) treatment.

In times of increasing medical care consumption leading to increasing health care costs the investigators have to adopt new ways of acquiring patient-specific knowledge and new ways of delivering care. To obtain this level of insight the investigators need a smart and connected health care system. With the ICU-Recover Box and its smart technology we see new opportunities to improve patient health and to recognise early if escalation of medical care is needed. By intervening early the investigators can reduce costs by reducing health care utilization.

Objectives: The primary objective of the pilot study is to assess the feasibility of the introduction and use of smart technology by persons that have been discharged from the ICU in the three months following hospital discharge. If this pilot study proves to be successful, smart technology will be used in future studies.

Study design: This is a single center cohort study. Study population: The study population consists of 15 patients who have been discharged from the ICU Department to a general ward of the Leiden University Medical Centre.

Intervention: Patients who consent to take part in the study, receive an ICU-Recover Box closely before hospital discharge on the general ward. The ICU-Recover Box will contain a smartphone compatible blood pressure monitor, weight scale, and a watch containing a peripheral oxygen saturation monitor, a pedometer to monitor activity for home monitoring. Never will results of any of the measurements be used for therapy or diagnosis.

Main study parameters/endpoints: The primary endpoint of the study will be the feasibility of providing and following ICU patients with smart technology for three months after discharge from a general ward of the Leiden University Medical Centre.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
10 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
10 patients who have been admitted to the ICU, at the Leiden University Medical Centre, and have been discharged to home will be using home monitoring for 3 consecutive months after hospital discharge10 patients who have been admitted to the ICU, at the Leiden University Medical Centre, and have been discharged to home will be using home monitoring for 3 consecutive months after hospital discharge
Masking:
None (Open Label)
Primary Purpose:
Device Feasibility
Official Title:
The ICU-recover Box, Using Smart Technology for Monitoring Health Status After ICU Admission
Actual Study Start Date :
Sep 26, 2022
Anticipated Primary Completion Date :
May 31, 2023
Anticipated Study Completion Date :
Aug 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Patients receiving the ICU-recover box containing home monitoring devices

Treatment of subjects on the ICU will be state of the art, conform current practice, protocols and guidelines. Patients discharged from the ICU will receive an ICU-Recover Box on one of the clinical wards of the LUMC filled with several devices after they have given informed consent. These devices are listed below and are described in further detail in section 6 of this protocol. The ICU-Recover Box contains the following devices and tools: Withings BPM Connect Withings Body weight scale Withings ScanWatch, from which the following features will be used: Measurement of SpO2 Automatic recording of heart rate Automatic recording of activity (step count)

Device: Withings ScanWatch
Withings ScanWatch, from which the following features will be used: Measurement of peripheral oxygen saturation (%) Automatic recording of heart rate (beats/min) Automatic recording of activity (step count) (numbers/day)

Device: Withings BPM Connect
Withings BPM connect, from which the following feature will be used: o Measurement of non invasive bloodpressure (mmHg)

Device: Withings Body
Withings Body (Scale), from which the following feature will be used: o Measurement of body weight (kg)

Outcome Measures

Primary Outcome Measures

  1. Feasibility of using home monitoring devices in terms of patient number [three months]

    Primary endpoint of this study is the feasibility of providing patients with the ICU-Recover Box after ICU discharge and before hospital discharge, including the collection of measurement/questionnaire data after hospital discharge. This study will be used to identify the issues when implementing such a system. Feasibility is defined as: 10 post-ICU patients, who gave informed consent and who were discharged from hospital with the ICU-Recover Box, were able to use the devices within its intended use.

  2. Feasibility of using home monitoring devices in terms of data acquisition [three months]

    We were able to acquire data from the devices in the ICU-Recover Box. Heart rate ( beats/min ) from the Withings ScanWartch steps/day from the Withings ScanWatch peripheral oxygen saturation (%) from the Withings ScanWatch weight ( kg) from Withings Body Blood pressure ( mmHg) from Withings BPM Connect

  3. Feasibility of using home monitoring devices in terms of data storage [three months]

    · We were able to store the acquired data in a safe manner in the datasafe of the LUMC

  4. Feasibility of using home monitoring devices in terms of data analyzability [three to six months]

    · We were able to analyse the acquired data (using Python).

  5. Feasibility of using home monitoring devices [six months]

    · · > 80 % of the persons that were discharged with an ICU-Recover Box contributed for three months to post-ICU data

Secondary Outcome Measures

  1. Acceptability of home monitoring [three months]

    Secondary endpoints are: · Users, i.e. post-ICU patients, have been asked, by short interviews, for feedback and suggested a

  2. Improvements of home monitoring [three months]

    · By means of PDCA cycli, the lessons learned and feedback will have led to adjustment and improvement of the ICU-Recover Box, from its content and its use to data acquisition and data analysis.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

In order to be eligible to participate in this study, a subject must meet all of the following criteria:

  • Patient has been admitted to the ICU of the LUMC for > 48 hours.

  • Patient has received mechanical ventilation for > 24 hours.

  • Patient masters the English or Dutch language.

  • Patient is able and capable to use smart technology at home. (i.e. Wi-Fi available, sufficient comprehension of smart technology).

  • Patient can be contacted and informed about the ICU-Recover box on one of the clinical wards of the LUMC.

  • Patient is discharged from a ward within the LUMC to home..

Exclusion Criteria:
  • A potential subject who meets any of the following criteria will be excluded from participation in this study:

  • Patient is < 18 years old.

  • Patient is pregnant.

  • Patient breastfeeds during the course of the study

  • Patient underwent cardiothoracic surgery (as they will receive the Cardiothoracic Box in another study).

  • Patient is discharged for palliative care.

  • Patient is considered an incapacitated adult.

  • Patient is unwilling to sign the informed consent form.

  • Patient is discharged to another hospital.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Leiden University Medical Center Leiden Zuid-Holland Netherlands 2333 ZA

Sponsors and Collaborators

  • Leiden University Medical Center

Investigators

  • Principal Investigator: Sesmu Arbous, MD PhD, LUMC

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sesmu M. Arbous, MD PhD MSc, dr., Leiden University Medical Center
ClinicalTrials.gov Identifier:
NCT05766319
Other Study ID Numbers:
  • NL81044.058.22
First Posted:
Mar 13, 2023
Last Update Posted:
Mar 13, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sesmu M. Arbous, MD PhD MSc, dr., Leiden University Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 13, 2023